Latham & Watkins represented Viasat in the transaction while Morrison Foerster served as government contracts and regulatory counsel to L3Harris on regulatory matters. Viasat Inc. (NASDAQ: VSAT),...
L3Harris Technologies’ $1.96 Billion Acquisition of Link 16 Tactical Data Links Business From Viasat
Amgen’s $3.7 Billion Acquisition of ChemoCentryx
Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
DigitalBridge Investment Management and IFM’s $11 Billion Take-Private Acquisition of Switch
Latham & Watkins advised the Special Committee of the Board of Directors of Switch, and Simpson Thacher & Bartlett advised DigitalBridge and IFM on the deal....
Oaktree’s Investment in ITG Communications
Latham & Watkins LLP represented Oaktree in the transaction. ITG Communications, a national provider of installation, fulfillment, constructio, and project management services to the cable, telecommunications,...
American Express Global Business Travel’s Combination with SPAC Apollo Strategic Growth Capital
Credit Suisse, Goldman Sachs and Morgan Stanley & Co. LLC acted as financial advisors to American Express Global Business Travel, while Skadden, Arps, Slate, Meagher &...
Winc’s Initial Public Offering
Latham & Watkins represented Winc, Inc. in the offering. Manatt Represents Spartan Capital Securities LLC and Revere Securities LLC. Winc, Inc., one of the fastest growing at...
GE Healthcare’s $1.45 Billion Acquisition of BK Medical
Schiff Hardin advised BK Medical on the deal. Latham & Watkins represented Altaris Capital. GE Healthcare has entered into an agreement to acquire BK Medical, a...
Procept BioRobotics’ $163.9 Million Initial Public Offering
Latham & Watkins represented PROCEPT in the transaction. PROCEPT BioRobotics Corporation, a commercial-stage surgical robotics company focused on advancing patient care by developing transformative solutions in urology,...
Icosavax’s $209.3 Million IPO
Latham & Watkins represented Icosavax, while Wilmer Cutler Pickering Hale and Dorr advised the underwriters on the deal. Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its...
Erasca’s $345 Million Initial Public Offering
Latham & Watkins LLP and Wilson Sonsini Goodrich & Rosati represented Erasca in the transaction. Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on...
Four Corners Property Trust’s $650 Million Unsecured Credit Facility
Latham & Watkins LLP represented Four Corners Property Trust in the transaction. Four Corners Property Trust entered into a Second Amended and Restated Revolving Credit and Term...
Four Corners Property Trust’s $650 Million Unsecured Credit Facility
Latham & Watkins LLP represented Four Corners Property Trust in the transaction. Four Corners Property Trust entered into a Second Amended and Restated Revolving Credit and Term...